Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report

• There is a critical need for therapeutic options in uterine serous carcinoma (USC). • A substantial proportion of USC cases express estrogen receptors (ER). • This report describes use of letrozole therapy in recurrent, ER-positive USC. • Zoledronic acid may enhance letrozole efficacy against horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Najjar, Omar, Varghese, Aaron, Shahi, Maryam, Vang, Russell, Gaillard, Stephanie, Smith, Thomas, Fader, Amanda N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091228/
https://www.ncbi.nlm.nih.gov/pubmed/32215315
http://dx.doi.org/10.1016/j.gore.2020.100555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091228/
https://www.ncbi.nlm.nih.gov/pubmed/32215315
http://dx.doi.org/10.1016/j.gore.2020.100555

Ejemplares similares